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Department of Physiology, Universidade Federal de Sergipe, São Cristóvão, SE, Brazil.
SUMMARY. Cardiovascular effects induced by citronellal in rats were investigated in this study. In L-
NAME hypertensive rats, the oral acute administration of citronellal (200 mg/kg) was able to significantly
reduce the blood pressure. In normotensive rats, citronellal (5-40 mg/kg, i.v.) induced hypotension, which
was not affected by pre-treatment with atropine, hexamethonium, L-NAME or indomethacin, and brady-
cardia, which was abolished by atropine and hexamethonium, but not by L-NAME or indomethacin. ECG
records revealed that citronellal induced sinoatrial block, which was abolished after atropine. In intact
rings of rat mesenteric artery pre-contracted with phenylephrine (10 μM), citronellal (10–6 to 10–1 M) was
able to induce relaxations (Emax = 106.3 ± 9.4 %) that were not affected by endothelium removal or after
pre-contraction with KCl 80 mM. In conclusion, these results demonstrate that citronellal reduces blood
pressure. Furthermore, citronellal induces endothelium-independent vasorelaxation in rat artery that ap-
pears to involve inhibition of Ca2+ influx.
